STAAR Surgical Retained Earnings (Accumulated Deficit) 2010-2024 | STAA
STAAR Surgical retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
STAAR Surgical Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
2023 |
$-47 |
2022 |
$-69 |
2021 |
$-111 |
2020 |
$-136 |
2019 |
$-142 |
2018 |
$-156 |
2017 |
$-161 |
2016 |
$-159 |
2015 |
$-147 |
2014 |
$-140 |
2013 |
$-132 |
2012 |
$-132 |
2011 |
$-131 |
2010 |
$-132 |
2009 |
$-132 |
STAAR Surgical Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
2024-09-30 |
$-33 |
2024-06-30 |
$-43 |
2024-03-31 |
$-51 |
2023-12-31 |
$-47 |
2023-09-30 |
$-55 |
2023-06-30 |
$-64 |
2023-03-31 |
$-70 |
2022-12-31 |
$-69 |
2022-09-30 |
$-78 |
2022-06-30 |
$-89 |
2022-03-31 |
$-102 |
2021-12-31 |
$-111 |
2021-09-30 |
$-116 |
2021-06-30 |
$-122 |
2021-03-31 |
$-131 |
2020-12-31 |
$-136 |
2020-09-30 |
$-139 |
2020-06-30 |
$-143 |
2020-03-31 |
$-142 |
2019-12-31 |
$-142 |
2019-09-30 |
$-148 |
2019-06-30 |
$-151 |
2019-03-31 |
$-154 |
2018-12-31 |
$-156 |
2018-09-30 |
$-157 |
2018-06-30 |
$-159 |
2018-03-31 |
$-161 |
2017-12-31 |
$-161 |
2017-09-30 |
$-161 |
2017-06-30 |
$-162 |
2017-03-31 |
$-161 |
2016-12-31 |
$-159 |
2016-09-30 |
$-159 |
2016-06-30 |
$-157 |
2016-03-31 |
$-155 |
2015-12-31 |
$-147 |
2015-09-30 |
$-146 |
2015-06-30 |
$-144 |
2015-03-31 |
$-143 |
2014-12-31 |
$-140 |
2014-09-30 |
$-138 |
2014-06-30 |
$-135 |
2014-03-31 |
$-133 |
2013-12-31 |
$-132 |
2013-09-30 |
$-131 |
2013-06-30 |
$-132 |
2013-03-31 |
$-132 |
2012-12-31 |
$-132 |
2012-09-30 |
$-131 |
2012-06-30 |
$-131 |
2012-03-31 |
$-130 |
2011-12-31 |
$-131 |
2011-09-30 |
$-131 |
2011-06-30 |
$-131 |
2011-03-31 |
$-132 |
2010-12-31 |
$-132 |
2010-09-30 |
$-131 |
2010-06-30 |
$-130 |
2010-03-31 |
$-129 |
2009-12-31 |
$-132 |
2009-09-30 |
$-131 |
2009-06-30 |
$-129 |
2009-03-31 |
$-128 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$1.312B |
$0.322B |
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|